ABBV vs PFE
By Alex · Tickerpine
AbbVie Inc. vs Pfizer Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | PFE |
|---|---|---|
| Price | $295.03 | $28.89 |
| Market cap | $521.50B | $164.67B |
| P/E ratio | 50.7 | 41.3 |
| ROE | — | 4.47% |
| Profit margin | 15.67% | 6.34% |
| Revenue growth | 10.30% | -0.40% |
| Dividend yield | 2.35% | 5.95% |
| Beta | 0.19 | 0.30 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs PFE in plain English
- ABBV is the bigger company — about 3.2× the market cap of PFE.
- PFE is cheaper on earnings (P/E 41.3 vs 50.7).
- ABBV is growing revenue faster (10% vs -0%).
- PFE has the higher dividend yield (5.95% vs 2.35%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
PFE return calculator
See what $1,000 in Pfizer Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.